Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Journal of Medicinal Chemistry
|
November 17, 2015
Discovery of Inhibitors That Overcome the G1202R Anaplastic Lymphoma Kinase Resistance Mutation
John M Hatcher, Magda Bahcall, Hwan Geun Choi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 15, 2025
Editor's Note: Identification of Existing Drugs That Effectively Target NTRK1 and ROS1 Rearrangements in Lung Cancer
Curtis R Chong, Magda Bahcall, Marzia Capelletti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 3, 2016
Identification of Existing Drugs That Effectively Target NTRK1 and ROS1 Rearrangements in Lung Cancer
Curtis R Chong, Magda Bahcall, Marzia Capelletti, et al.
European Journal of Medicinal Chemistry
|
May 22, 2017
Discovery of a potent dual ALK and EGFR T790M inhibitor
Jaebong Jang, Jung Beom Son, Ciric To, et al.
Journal of Medicinal Chemistry
|
April 18, 2018
Chemically Induced Degradation of Anaplastic Lymphoma Kinase (ALK)
Chelsea E Powell, Yang Gao, Li Tan, et al.
Nature
|
March 3, 2022
Silent mutations reveal therapeutic vulnerability in RAS Q61 cancers
Yoshihisa Kobayashi, Chhayheng Chhoeu, Jiaqi Li, et al.
Cancer Research
|
June 7, 2015
Identification of Oncogenic and Drug-Sensitizing Mutations in the Extracellular Domain of FGFR2
Junko Tanizaki, Dalia Ercan, Marzia Capelletti, et al.
Cancer Research
|
April 2, 2017
Response Heterogeneity of EGFR and HER2 Exon 20 Insertions to Covalent EGFR and HER2 Inhibitors
Takayuki Kosaka, Junko Tanizaki, Raymond M Paranal, et al.
Cancer Discovery
|
October 4, 2016
Acquired METD1228V Mutation and Resistance to MET Inhibition in Lung Cancer
Magda Bahcall, Taebo Sim, Cloud P Paweletz, et al.
Molecular Cancer Therapeutics
|
November 18, 2021
Combination of Type I and Type II MET Tyrosine Kinase Inhibitors as Therapeutic Approach to Prevent Resistance
Magda Bahcall, Cloud P Paweletz, Yanan Kuang, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Journal of Medicinal Chemistry
|
November 17, 2015
Discovery of Inhibitors That Overcome the G1202R Anaplastic Lymphoma Kinase Resistance Mutation
John M Hatcher, Magda Bahcall, Hwan Geun Choi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 15, 2025
Editor's Note: Identification of Existing Drugs That Effectively Target NTRK1 and ROS1 Rearrangements in Lung Cancer
Curtis R Chong, Magda Bahcall, Marzia Capelletti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 3, 2016
Identification of Existing Drugs That Effectively Target NTRK1 and ROS1 Rearrangements in Lung Cancer
Curtis R Chong, Magda Bahcall, Marzia Capelletti, et al.
European Journal of Medicinal Chemistry
|
May 22, 2017
Discovery of a potent dual ALK and EGFR T790M inhibitor
Jaebong Jang, Jung Beom Son, Ciric To, et al.
Journal of Medicinal Chemistry
|
April 18, 2018
Chemically Induced Degradation of Anaplastic Lymphoma Kinase (ALK)
Chelsea E Powell, Yang Gao, Li Tan, et al.
Nature
|
March 3, 2022
Silent mutations reveal therapeutic vulnerability in RAS Q61 cancers
Yoshihisa Kobayashi, Chhayheng Chhoeu, Jiaqi Li, et al.
Cancer Research
|
June 7, 2015
Identification of Oncogenic and Drug-Sensitizing Mutations in the Extracellular Domain of FGFR2
Junko Tanizaki, Dalia Ercan, Marzia Capelletti, et al.
Cancer Research
|
April 2, 2017
Response Heterogeneity of EGFR and HER2 Exon 20 Insertions to Covalent EGFR and HER2 Inhibitors
Takayuki Kosaka, Junko Tanizaki, Raymond M Paranal, et al.
Cancer Discovery
|
October 4, 2016
Acquired METD1228V Mutation and Resistance to MET Inhibition in Lung Cancer
Magda Bahcall, Taebo Sim, Cloud P Paweletz, et al.
Molecular Cancer Therapeutics
|
November 18, 2021
Combination of Type I and Type II MET Tyrosine Kinase Inhibitors as Therapeutic Approach to Prevent Resistance
Magda Bahcall, Cloud P Paweletz, Yanan Kuang, et al.
Page
of 2